Posts: 4,335
Threads: 96
Joined: Aug 2011
Reputation:
85
Yesterday, 08:55 AM
(This post was last modified: Yesterday, 08:56 AM by weijian.)
With FY25 results further deteriorating from FY24, Avi-Tech is now trading at net cash. The PPE depreciation is probably conservative and so actual replacement cost should be much higher.
So there we have it - (1) traded market value undervalues the balance sheet, (2) Major customers look to have reduced their wallet spent permanently. (3) Controlling shareholders (but total share ownership still <50%) are generous per say as dividend payout ratio had always been relatively consistent at ~90% NP, (4) Permanent 500k loss in Hyflux 4.25% bonds. Also invested 500k for a 9% stake in Movel AI in 2021 and fully written off (associate accounting) after 3 years.
Will be interesting to observe how this evolves in current market.
RESPONSES TO QUESTIONS FROM THE SECURITIES INVESTORS ASSOCIATION (SINGAPORE) IN RELATION TO THE COMPANY’S FY2025 ANNUAL REPORT
Q3. According to the SGX Stock Screener1, the company trades at a price-to-book ratio of 0.7 times and has a market capitalisation of approximately $36 million. The enterprise value is negative $1.5 million given that the group held cash balance of $37.4 million as at 30 June 2025.
https://links.sgx.com/FileOpen/Avi-Tech%...eID=864496
I am not a certified financial advisor and so nothing of what I say should be construed as financial advice. Please consult a certified financial advisor for advice instead.